Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „Pegfilgrastim“
Suchtreffer
Begriffe & Kennungen
Cavoley · 4.5 · Due to the potential sensitivity of rapidly dividing myeloid cells to cytotoxic chemotherapy‚ pegfilgrastim sh
Eintrag öffnenCavoley · 4.5 · The safety and efficacy of pegfilgrastim have not been evaluated in patients receiving chemotherapy associated
Eintrag öffnenCavoley · 4.8 · Uncommon events of cutaneous vasculitis have been reported in patients treated with pegfilgrastim. The mechani
Eintrag öffnenCegfila (previously Pegfilgrastim Mundipharma)
Eintrag öffnenCegfila (previously Pegfilgrastim Mundipharma) · 4.1 Therapeutic indications · 1
Eintrag öffnenCegfila (previously Pegfilgrastim Mundipharma) · 4.3 Contraindications · 1
Eintrag öffnenCegfila (previously Pegfilgrastim Mundipharma) · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenCegfila (previously Pegfilgrastim Mundipharma) · 4.4 Special warnings and precautions for use · 1
Eintrag öffnenCegfila (previously Pegfilgrastim Mundipharma) · 4.5 Interaction with other medicinal products and other forms of interaction · 1
Eintrag öffnenCegfila (previously Pegfilgrastim Mundipharma) · 4.5 · Due to the potential sensitivity of rapidly dividing myeloid cells to cytotoxic chemotherapy‚ Cegfila should b
Eintrag öffnenCegfila (previously Pegfilgrastim Mundipharma) · 4.5 · Possible interactions with other haematopoietic growth factors and cytokines have not been specifically invest
Eintrag öffnenCegfila (previously Pegfilgrastim Mundipharma) · 4.5 · Specific interaction or metabolism studies have not been performed, however, clinical trials have not indicate
Eintrag öffnenCegfila (previously Pegfilgrastim Mundipharma) · 4.5 · The potential for interaction with lithium, which also promotes the release of neutrophils, has not been speci
Eintrag öffnenCegfila (previously Pegfilgrastim Mundipharma) · 4.5 · The safety and efficacy of Cegfila have not been evaluated in patients receiving chemotherapy associated with
Eintrag öffnenCegfila (previously Pegfilgrastim Mundipharma) · 4.6 Fertility, pregnancy and lactation · 1
Eintrag öffnenCegfila (previously Pegfilgrastim Mundipharma) · 4.8 Undesirable effects · 1
Eintrag öffnenCegfila (previously Pegfilgrastim Mundipharma) · 4.8 · 6 MedDRA Adverse reactions system organ Very Common Uncommon Rare Very rare class common (≥ 1/10) (≥ 1/100 (≥
Eintrag öffnenCegfila (previously Pegfilgrastim Mundipharma) · 4.8 · 7 MedDRA Adverse reactions system organ Very Common Uncommon Rare Very rare class common (≥ 1/10) (≥ 1/100 (≥
Eintrag öffnenCegfila (previously Pegfilgrastim Mundipharma) · 4.8 · An increased risk of MDS/AML following treatment with pegfilgrastim in conjunction with chemotherapy and/or ra
Eintrag öffnenCegfila (previously Pegfilgrastim Mundipharma) · 4.8 · Capillary leak syndrome, which can be life-threatening if treatment is delayed, has been reported as uncommon
Eintrag öffnen